1. Home
  2. ANIP vs METC Comparison

ANIP vs METC Comparison

Compare ANIP & METC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • METC
  • Stock Information
  • Founded
  • ANIP 2001
  • METC 2015
  • Country
  • ANIP United States
  • METC United States
  • Employees
  • ANIP N/A
  • METC N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • METC Coal Mining
  • Sector
  • ANIP Health Care
  • METC Energy
  • Exchange
  • ANIP Nasdaq
  • METC Nasdaq
  • Market Cap
  • ANIP 2.0B
  • METC 1.6B
  • IPO Year
  • ANIP N/A
  • METC 2017
  • Fundamental
  • Price
  • ANIP $98.30
  • METC $24.14
  • Analyst Decision
  • ANIP Strong Buy
  • METC Strong Buy
  • Analyst Count
  • ANIP 9
  • METC 3
  • Target Price
  • ANIP $86.00
  • METC $21.67
  • AVG Volume (30 Days)
  • ANIP 488.4K
  • METC 2.9M
  • Earning Date
  • ANIP 11-07-2025
  • METC 11-03-2025
  • Dividend Yield
  • ANIP N/A
  • METC 2.27%
  • EPS Growth
  • ANIP N/A
  • METC N/A
  • EPS
  • ANIP N/A
  • METC N/A
  • Revenue
  • ANIP $747,399,000.00
  • METC $625,919,000.00
  • Revenue This Year
  • ANIP $39.32
  • METC $0.82
  • Revenue Next Year
  • ANIP $9.62
  • METC $19.59
  • P/E Ratio
  • ANIP N/A
  • METC N/A
  • Revenue Growth
  • ANIP 38.68
  • METC N/A
  • 52 Week Low
  • ANIP $52.50
  • METC $5.90
  • 52 Week High
  • ANIP $99.50
  • METC $28.40
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 77.93
  • METC 50.63
  • Support Level
  • ANIP $96.50
  • METC $24.84
  • Resistance Level
  • ANIP $99.50
  • METC $28.40
  • Average True Range (ATR)
  • ANIP 2.17
  • METC 1.69
  • MACD
  • ANIP -0.33
  • METC -0.28
  • Stochastic Oscillator
  • ANIP 87.17
  • METC 15.47

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About METC Ramaco Resources Inc.

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

Share on Social Networks: